Ind-Swift Laboratories Limited — Important, 04-07-2025: Updates

Essix Biosciences Limited, a promoter of Ind-Swift Laboratories, has acquired 11 lakh equity shares by converting fully convertible warrants. This increases Essix’s stake to 34.86% from 33.83%, reflecting a strategic capital infusion through preferential allotment at Rs. 121 per share. The transaction boosts promoter holding and strengthens their control, potentially supporting future operational and financial initiatives.